US Medical Digital Imaging System Market Report 2023 to 2030

US Medical Digital Imaging System Market Analysis

$ 3999

The US Medical Digital Imaging System Market was valued at $12810 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $19517.35 Mn by 2030. The key drivers of this industry include the aging population, focus on preventive care, and technology advancements. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.

ID: IN10USDH156 CATEGORY: Digital Health GEOGRAPHY: US AUTHOR: Aashwi Mehta

Buy Now

US Medical Digital Imaging System Market Executive Summary

The US Medical Digital Imaging System Market was valued at $12810 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $19517.35 Mn by 2030.

Medical digital imaging systems encompass a variety of technologies used in healthcare to produce visual representations of the body's interior for clinical analysis and medical intervention. These systems have advanced significantly, becoming pivotal in modern medicine by aiding in the diagnosis and treatment of diseases. Medical imaging includes ultrasound, x-rays, computed tomography (CT scans), Magnetic Resonance Imaging (MRI), and nuclear medicine technologies.

There were 74 Mn CT procedures in the US, accounting for approximately 18% of the world's estimated total, and 13.5 Mn nuclear medicine procedures, representing 34% of the global total. The market is driven by significant factors like the aging population, focus on preventive care, and technology advancements. However, shortage of staff, high cost, and regulatory hurdles restrict the growth and potential of the market.

Prominent players in this field include Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.

US Medical Digital Imaging System Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Aging Population: The U.S. is experiencing a demographic shift with an increasing proportion of people aged 65 and older. By 2030, 1 in 5 Americans will be 65 or older, and this age group is projected to nearly double from 52 Mn to 95 Mn by 2060. This aging population drives the demand for medical imaging systems, as older adults typically require more frequent diagnostic imaging for age-related health conditions and chronic diseases, thereby fueling market growth.

Focus on Preventive Care: The growing emphasis on preventive healthcare in the U.S. relies on medical imaging for early disease detection. Early intervention through imaging improves patient outcomes and reduces healthcare costs, driving demand for advanced imaging technologies and market expansion.

Technological Advancements: Innovations in medical imaging, including AI, enable more precise diagnoses, personalized treatments, and minimally invasive procedures. AI-powered imaging enhances the accuracy of detecting cancers and other abnormalities, driving the adoption of advanced imaging systems and boosting the market in the U.S.

Market Restraints

Shortage of staff: According to the Association of American Medical Colleges (AAMC), the U.S. is expected to face a shortage of 17,000 to 42,000 radiologists, pathologists, and psychiatrists by 2033. This shortage poses a significant market restraint for medical device imaging systems, as the lack of qualified professionals to operate and interpret these advanced technologies can hinder their effective use and integration into healthcare practices.

High Cost: Imaging systems can be prohibitively expensive to maintain, especially for smaller healthcare organizations with limited resources. This cost barrier limits these facilities' capacity to purchase and integrate new imaging technology, which in turn limits market expansion.

Regulatory Hurdles: The regulatory environment for medical imaging devices in the U.S. is continuously evolving. The Food and Drug Administration (FDA) imposes stringent standards for device approval, requiring manufacturers to navigate this complex process to introduce new technologies to the market. This can lead to delays and uncertainties for manufacturers, hindering market growth.

Regulatory Landscape and Reimbursement Scenario

The US Food and Drug Administration (US FDA) 's Center for Devices and Radiological Health (CDRH) oversees the regulation of companies that manufacture, repackage, relabel, and/or import medical devices sold in the United States. Additionally, the CDRH regulates radiation-emitting electronic products, both medical and non-medical, including lasers, x-ray systems, and ultrasound equipment. The U.S. Medicare program, offering health insurance for seniors and individuals with disabilities, covers an extensive range of medically necessary diagnostic imaging services. The Centers for Medicare & Medicaid Services (CMS) set the reimbursement rates for these services.

Competitive Landscape

Key Players

Here are some of the major key players in the US Medical Digital Imaging System Market:

Siemens Healthineers
GE Healthcare
Philips Healthcare
Canon Medical Systems
Hitachi Medical
Fujifilm
Carestream
Konica Minolta
Shimadzu
Hologic

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

US Medical Digital Imaging System Market Segmentation

By Type

X-Ray
MRI
CT scan
Ultrasound
Others

By Technology

2D Imaging System
3D/4D Imaging System

By Application

Orthopedics
Oncology
Cardiology
Neurology
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.